TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013